|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.166
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.126
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.118
|
Human |
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.107
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.105
|
Human |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.087
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.082
|
Human |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.075
|
Human |
|
|
dna recombination
|
GO:0006310 |
92 |
0.051
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.050
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.049
|
Human |
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.049
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.047
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.044
|
Human |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.041
|
Human |
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.040
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.039
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.039
|
Human |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.038
|
Human |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.038
|
Human |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.037
|
Human |
|
|
double strand break repair
|
GO:0006302 |
48 |
0.036
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.036
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.034
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.034
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.034
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
Human |
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
Human |
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.032
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.031
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.030
|
Human |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
Human |
|
|
chromatin organization
|
GO:0006325 |
206 |
0.028
|
Human |
|
|
negative regulation of dna recombination
|
GO:0045910 |
13 |
0.027
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.027
|
Human |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.026
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.025
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.025
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.025
|
Human |
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.025
|
Human |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
Human |
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.024
|
Human |
|
|
meiosis i
|
GO:0007127 |
60 |
0.024
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.024
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.023
|
Human |
|
|
protein maturation
|
GO:0051604 |
176 |
0.023
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.023
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.023
|
Human |
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.022
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.022
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
Human |
|
|
response to radiation
|
GO:0009314 |
165 |
0.021
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
somatic diversification of immune receptors via somatic mutation
|
GO:0002566 |
8 |
0.021
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.021
|
Human |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.021
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
Human |
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.020
|
Human |
|
|
nuclear division
|
GO:0000280 |
158 |
0.020
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.020
|
Human |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.019
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
Human |
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
Human |
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.018
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.018
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.018
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
Human |
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.017
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
Human |
|
|
protein processing
|
GO:0016485 |
163 |
0.017
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.017
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
Human |
|
|
rna processing
|
GO:0006396 |
105 |
0.016
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.016
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.016
|
Human |
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.015
|
Human |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.015
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.015
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.015
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.015
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
Human |
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.014
|
Human |
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.014
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
Human |
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.013
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.013
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.013
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.013
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.013
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.013
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
|
recombinational repair
|
GO:0000725 |
21 |
0.013
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.013
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.013
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.013
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.013
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.013
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.012
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.012
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.012
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.012
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.012
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
Human |
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.012
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.012
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.012
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.012
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.012
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.011
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.011
|
Human |
|
|
sperm motility
|
GO:0030317 |
47 |
0.011
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.011
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.011
|
|
|
|
mitotic recombination
|
GO:0006312 |
3 |
0.011
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.011
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.011
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.011
|
|
|
|
chiasma assembly
|
GO:0051026 |
6 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.011
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.011
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.011
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.011
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.010
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.010
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.010
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.010
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.010
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.010
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.010
|
Human |
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.010
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.010
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.010
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.010
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.010
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.010
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.010
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.010
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.010
|
Human |